MAPK13 Inhibitor Compound 61 25 mg | ≥98% Cayman Chemical A p38d MAPK inhibitor More Information Supplier Page × MAPK13 Inhibitor Compound 61
MAPK13 Inhibitor Compound 61 10 mg | ≥98% Cayman Chemical A p38d MAPK inhibitor More Information Supplier Page × MAPK13 Inhibitor Compound 61
RGX-104 50 mg | ≥98% Cayman Chemical An LXRa and LXRß agonist More Information Supplier Page × RGX-104
RGX-104 5 mg | ≥98% Cayman Chemical An LXRa and LXRß agonist More Information Supplier Page × RGX-104
RGX-104 25 mg | ≥98% Cayman Chemical An LXRa and LXRß agonist More Information Supplier Page × RGX-104
RGX-104 10 mg | ≥98% Cayman Chemical An LXRa and LXRß agonist More Information Supplier Page × RGX-104
BTT3033 50 mg | ≥98% Cayman Chemical An integrin a2ß1 inhibitor More Information Supplier Page × BTT3033
BTT3033 100 mg | ≥98% Cayman Chemical An integrin a2ß1 inhibitor More Information Supplier Page × BTT3033
BTT3033 10 mg | ≥98% Cayman Chemical An integrin a2ß1 inhibitor More Information Supplier Page × BTT3033
